Teva Pharmaceutical Industries Ltd Adr (TEVA)

Jun 17, 2025

Can Teva- Pharmaceutical Industries Ltd. ADR Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com

Jun 17, 2025

Jun 16, 2025

Billionaire Stanley Druckenmiller Dumped His Entire Stake in Palantir and Has Piled Into This Suddenly Unstoppable Drug Stock for 3 Straight Quarters - The Motley Fool

Jun 16, 2025

Jun 09, 2025

Stocks Generating Improved Relative Strength: Teva Pharmaceutical ADR - MSN

Jun 09, 2025

May 29, 2025

Teva: New Long-Term Targets and Sold Pipeline Reaffirm Our Favorable Outlook; Shares Undervalued - Morningstar

May 29, 2025

May 29, 2025

Teva: New Long-Term Targets and Solid Pipeline Reaffirm Our Favorable Outlook; Shares Undervalued - Morningstar

May 29, 2025

May 28, 2025

TEVA Begins IND-Enabling Studies on Inflammatory Disease Candidate - Yahoo Finance

May 28, 2025

May 20, 2025

Restart of Student Loan Repayments Could Squeeze Consumer Spending and Slow Economic Growth - iHeart

May 20, 2025

May 19, 2025

Bio/Pharmaceutical Outsourcing Report, March 2025 Edition - GlobeNewswire Inc.

May 19, 2025

May 12, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

May 12, 2025

May 07, 2025

Teva Earnings: Innovation Propels Sales and Generics Show Stability in Solid Start to the Year - Morningstar

May 07, 2025

May 05, 2025

Teva and Alvotech stocks jump on FDA approval of SELARSDI - Investing.com

May 05, 2025

May 05, 2025

Teva and Alvotech stocks jump on FDA approval of SELARSDI By Investing.com - Investing.com Canada

May 05, 2025

Apr 30, 2025

There Are Mixed Signals on the Chart for Teva- Pharmaceutical Industries Ltd. ADR (TEVA) - uspostnews.com

Apr 30, 2025

Apr 30, 2025

Digi Power X Inc (DGXX)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com

Apr 30, 2025

Apr 29, 2025

Market Analysts see Norwegian Cruise Line Holdings Ltd [NCLH] gaining to $21. Time to buy? - dbtnews.com

Apr 29, 2025

Apr 29, 2025

PG&E Corp [PCG] Revenue clocked in at $24.54 billion, down -14.37% YTD: What’s Next? - dbtnews.com

Apr 29, 2025

Apr 29, 2025

Greenwave Technology Solutions Inc [GWAV] Is Currently 12.13 above its 200 Period Moving Avg: What Does This Mean? – The DBT News - dbtnews.com

Apr 29, 2025

Apr 29, 2025

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Performance and Fundamentals Dashboard tells a completely different story – Sete News - Sete News

Apr 29, 2025

Apr 29, 2025

Raymond James slashes price target on Adma Biologics Inc [ADMA] – find out why. - dbtnews.com

Apr 29, 2025

Apr 28, 2025

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: A Year of Highs and Lows - investchronicle.com

Apr 28, 2025

Apr 28, 2025

Company’s Banking Stock: Dissecting a 37.52% Quarterly Revenue Decline Amid Growth - investchronicle.com

Apr 28, 2025

Apr 28, 2025

NEOV’s Market Whiplash: -48.46% YTD Decline, 15.24% Rise in 30 Days - investchronicle.com

Apr 28, 2025

Apr 28, 2025

Adagio Medical Holdings Inc (ADGM) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com

Apr 28, 2025

Apr 25, 2025

A company insider recently sold 70,961 shares of Teva- Pharmaceutical Industries Ltd. ADR [TEVA]. Should You Sale? - knoxdaily.com

Apr 25, 2025

Apr 24, 2025

Introducing Our Rant Against Teva- Pharmaceutical Industries Ltd. ADR - uspostnews.com

Apr 24, 2025

Apr 24, 2025

OS overperforms with a 2.12 increase in share price - uspostnews.com

Apr 24, 2025

Apr 23, 2025

For Kopin Corp [KOPN], Analyst sees a rise to $2. What next? - dbtnews.com

Apr 23, 2025

Apr 23, 2025

Market Analysts see Geron Corp [GERN] falling to $2. Time to buy? - dbtnews.com

Apr 23, 2025

Apr 23, 2025

Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Is Currently 5.18 below its 200 Period Moving Avg: What Does This Mean? – The DBT News - dbtnews.com

Apr 23, 2025

Apr 22, 2025

The growth track for Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has changed recently - Sete News

Apr 22, 2025

Apr 22, 2025

Rezolute Inc: Weathering Stock Market Storms with 190.08M Market Cap - investchronicle.com

Apr 22, 2025

Apr 22, 2025

Ready to Jump After Recent Trade: NIO Inc ADR (NIO) - Sete News

Apr 22, 2025

Apr 21, 2025

Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: Exploring a Year of Highs, Lows, and Trading Volume - investchronicle.com

Apr 21, 2025

Apr 21, 2025

ORCL’s Stock Journey: What Investors Need to Know About Oracle Corp’s Performance - investchronicle.com

Apr 21, 2025

Apr 21, 2025

TGB Stock Update: Taseko Mines Ltd’s Banking’s Market Struggles and Potential Opportunities - investchronicle.com

Apr 21, 2025

Apr 21, 2025

Lexicon Pharmaceuticals Inc (LXRX) Stock: A Year of Market Fluctuations - investchronicle.com

Apr 21, 2025

Apr 21, 2025

HESM’s latest rating updates from top analysts. - knoxdaily.com

Apr 21, 2025

Apr 21, 2025

Analysts review Teva- Pharmaceutical Industries Ltd. ADR’s rating - knoxdaily.com

Apr 21, 2025

Apr 16, 2025

Zacks Industry Outlook Dr. Reddy's, Sandoz And Teva Pharmaceuticals - Barchart.com

Apr 16, 2025

Apr 02, 2025

Is Vera Therapeutics Inc (VERA) a threat to investors? - uspostnews.com

Apr 02, 2025

Apr 02, 2025

What technical indicators reveal about MYGN stock - uspostnews.com

Apr 02, 2025

Apr 02, 2025

VF Corp (VFC) is a good investment, but the stock may be overvalued - uspostnews.com

Apr 02, 2025

Apr 02, 2025

Investing in Calumet Inc (CLMT) might be an excellent idea, but the stock is currently overvalued/undervalued - uspostnews.com

Apr 02, 2025

Apr 02, 2025

Wabash National Corp (WNC) stock on the rise: An overview - uspostnews.com

Apr 02, 2025

Apr 02, 2025

The Gryphon Digital Mining Inc (GRYP) had a good session last reading, didn’t it? - uspostnews.com

Apr 02, 2025

Apr 02, 2025

Generics Industry: India Celebrates Pharmaceutical Tariffs Exemption but Uncertainty Remains High - Morningstar

Apr 02, 2025

Mar 27, 2025

What will the future hold for CarGurus Inc (NASDAQ:CARG) stock? - US Post News

Mar 27, 2025

Mar 25, 2025

TEVA’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Mar 25, 2025